Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
|2||Active, not recruiting||
Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
A PET Study With RO5545965 in Healthy Male Volunteers
First Time in Human Study (FTIH) With Positron Emission Tomography (PET)
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Cognitive Remediation in 22q11DS
INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1
PET Neuroimaging of [11C]Mirtazapine
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
† Study has passed its completion date and status has not been verified in more than two years.